A universal flu vaccine is not impossible for the industry – we just need bioinformatics.

Tablets are the most common dosage form, but have you considered all of your options?

Can supersaturation save us from solubility problems?

Bioterrorism concerns prompt the UK government to fund development of a vaccine for plague.

Genentech’s Cell Culture Biologics Drug Substance Plant 2 in Vacaville, California.

The EMA says “yes” to transparency, but some pharma companies have other ideas.

A consortium of vendors and pharma companies search for a single, serialization standard.

Are reduced GDUFA fees on the horizon for contract manufacturers?

Lyophilized gene networks synthesize biomedicines ondemand – with just a sprinkle of water.

Why has Médecins Sans Frontières rejected an offer of free vaccines from Pfizer?